New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense bleeding events during endovascular-related procedures by using sensors to detect relative changes in tissue bioimpedance.
Visit WebsiteResults from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) rapidly and effectively reduces pressure and volume in the heart. This is the first study targeting the SVC as a therapeutic area for heart failure patients to reduce cardiac filling pressures without reducing cardiac output or systemic blood pressure.
Visit WebsiteInitial results from the AVIATOR 2 international registry were presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions, May 19-22 in Las Vegas. The AVIATOR 2 is a multicenter prospective observational study of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in 11 international sites. The use of a novel smartphone-based survey shows potential to improve outcomes by accessing the patient need for new tools to quantify risk.
Visit WebsiteTerumo Medical Corp. is recalling the SoloPath Balloon Expandable TransFemoral System and Re-Collapsible Balloon Access System due to a potential for the tip to dislodge from the outer rim of the sheath. This may result in a loss of the smooth transition from the surface of the tip to the outer surface of the expandable sheath.
Visit WebsiteRoyal DSM recently announced a collaboration with Strait Access Technologies (SAT), to develop the world’s first durable and cost-effective transcatheter replacement heart valves with polymeric leaflets.
Visit WebsiteWhen Andreas Grüntzig, father of percutaneous transluminal coronary angioplasty, approached his cardiac surgeon colleague Åke Senning for support in applying newly-developed angioplastic techniques to the coronary arteries, Dr. Senning enthusiastically responded, “You will take away my patients, but get started!” Senning foresaw what Grüntzig was setting in motion — the development of the discipline of interventional cardiology, destined to become a field of practice positioned to bring lifesaving therapies to patients whose bodies struggle to recover from the traumatic insult of open surgery.
Visit WebsiteA 72-year-old woman from northern Michigan became Henry Ford Health System’s 1,000th patient treated with the aid of 3-D printing technology.
Visit WebsitePhysicians use many strategies to better interface with patients and their families to try and explain in non-physician terms basic cardiac conditions and how the various subspecialties are involved. My favorite is the analogy of cardiac conditions related to owning an old house and all the issues the homeowner can face, including plumbing issues, electrical issues and structural issues. As an owner of a house built in the 1890s and finding myself doing the majority of the constant repairs, I found these comparisons to be spot on.
Visit WebsiteInvestigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial at the 2019 EuroPCR Annual Meeting, May 20-23 in Paris, France. The data indicate that renal denervation (RDN) with the Medtronic Symplicity renal denervation system was associated with reduced occurrence of subclinical atrial fibrillation (AF) in a small subset of high-risk patients with hypertensive heart disease over a median follow-up period of more than two years.
Visit WebsiteAt the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement to acquire Rhythm Xience Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s mapping and visualization technology platform.
Visit Website